Detalhe da pesquisa
1.
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma.
Br J Cancer
; 120(5): 512-521, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765873
2.
Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy.
Eur J Cancer
; 176: 110-120, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208569